Astrazeneca Business Analyst interview typically runs 2 rounds: SHL assessment and formal interview. The process usually takes a few weeks and is notably values-driven.
$107K
Avg. Base Comp
$145K
Avg. Total Comp
2
Typical Rounds
2-4 weeks
Process Length
We’ve seen AstraZeneca lean hard into values alignment for Business Analyst candidates, and that shows up as more than a polite culture check. In the experience we reviewed, the interview felt structured and checklist-driven, with direct prompts about holding someone accountable to do the right thing and why the candidate wanted AstraZeneca specifically. That tells us they are listening for judgment, not just polished storytelling. Candidates who can connect their examples to the company’s ethics and decision-making style tend to come across as credible; those who stay generic often feel like they’re missing the point.
A recurring theme is that AstraZeneca also expects practical business fluency under time pressure. The assessment was described as numerical but grounded in everyday work — percentages, timetable-style calculations, and quick interpretation of business scenarios. That’s a useful signal: they’re not trying to turn Business Analysts into statisticians, but they do want people who can stay accurate when the numbers are simple and the clock is not. The non-obvious make-or-break here is the combination of speed and precision with a very explicit values lens. Our candidates report that the strongest responses are the ones that are concise, concrete, and clearly tied back to how AstraZeneca operates.
Synthesized from 1 candidate report by our editorial team.
Had an interview recently?
Share your experience. Unlock the full guide.
Real interview reports from people who went through the Astrazeneca process.
The first step in my AstraZeneca Business Analyst process was a job-focused SHL assessment rather than a live interview, which I actually found a bit unexpected. It was mostly numerical and behavioral, and the numerical section was timed. The math itself was fairly practical, things like percentages and timetable-style calculations, so it felt more like testing how quickly and accurately I could work through business scenarios than anything overly technical. After that, the process moved into a more formal interview stage, and that was where the tone became pretty structured and a little uncomfortable at times. The questions were very values-driven, and it was clear they wanted to see how I thought through situations and whether my answers aligned with AstraZeneca’s values. One of the main questions I got was about a time I held someone accountable for doing the right thing, and another was a straightforward motivation question about why I wanted the role and why AstraZeneca specifically. The interview felt less like a conversation and more like being evaluated against a checklist, so I had to be very deliberate in tying my examples back to their values and keeping my answers focused. Overall, the process was multi-stage and fairly average in terms of experience, but the main thing I took away was that they care a lot about values fit as well as basic numerical comfort. I didn’t get an offer, so I’d say preparation should be centered on AstraZeneca’s values and on being quick with timed numerical exercises, especially percentage and scheduling-style questions.
Prep tip from this candidate
Study AstraZeneca’s values closely and prepare examples that show accountability and ethical judgment, since those came up directly. Also practice timed SHL-style numerical questions, especially percentages and timetable calculations, because the first round was assessment-based rather than conversational.
Share your own interview experience to unlock all reports, or subscribe for full access.
Sourced from candidate reports and verified by our team.
Topics based on recent interview experiences.
Featured question at Astrazeneca
Describing a data project and its challenges
| Question | |
|---|---|
| Client Solution Pushback | |
| Regularization and Validation | |
| 2nd Highest Salary | |
| Cumulative Distribution | |
| Monthly Customer Report | |
| Experiment Validity | |
| Brain Cancer Treatment Outcomes | |
| Total Spent on Products | |
| P-value to a Layman | |
| Last Transaction | |
| Fair Coin | |
| Size of Joins | |
| Cumulative Reset | |
| Always Excited Users | |
| Retailer Data Warehouse | |
| Reducing Error Margin | |
| Detecting ECG Tachycardia Runs | |
| Rider Discount | |
| Time Difference | |
| Causal Email Journey | |
| Search Linked List | |
| Count Transactions | |
| Subscription Retention | |
| Slow SQL Query | |
| DDoS Attack Response | |
| Licensing Valuation | |
| String Palindromes | |
| Loan Model | |
| Addressing Data Quality Issues |
Synthesized from candidate reports. Individual experiences may vary.
The process appears to start with a review of the candidate’s application before any live conversation. In this case, the first formal step that followed was an assessment rather than an immediate recruiter call, suggesting AstraZeneca uses an early filter to screen for fit before moving candidates forward.
Candidates complete a job-focused SHL assessment as the first active stage of the process. It includes timed numerical questions, such as percentages and timetable-style calculations, plus behavioral items, and is designed to test quick, accurate business reasoning as well as basic values alignment.
After the assessment, candidates move into a formal interview that is highly structured and somewhat checklist-driven. The questions are values-based and include prompts about holding someone accountable for doing the right thing, along with motivation questions about the role and why AstraZeneca specifically.
The interview experience suggests the final decision is heavily influenced by how well the candidate’s examples and reasoning align with AstraZeneca’s values. The process felt evaluative rather than conversational, so answers need to be deliberate, focused, and clearly tied back to the company’s expectations.
